Role of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA in intrahepatic cholangiocarcinoma

Surgery Today

Volumn 42, Issue 2, 2012, Pages 135-140

  Morine, Yuji ^a   Shimada, Mitsuo ^a   Utsunomiya, Tohru ^a   Imura, Satoru ^a   Ikemoto, Tetsuya ^a   Hanaka, Jun ^a   Kanamoto, Mami ^a   Kurita, Nobuhiro ^a   Miyake, Hidenori ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

5 FU regulated gene; Independent prognostic factor; Intrahepatic cholangiocarcinoma

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE; MESSENGER RNA; THYMIDYLATE SYNTHASE;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER CLASSIFICATION; CANCER INFILTRATION; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DANENBERG TUMOR PROFILE; FEMALE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; SURVIVAL RATE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; DIHYDROURACIL DEHYDROGENASE (NADP); DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; RETROSPECTIVE STUDIES; RNA, MESSENGER; THYMIDYLATE SYNTHASE; TUMOR MARKERS, BIOLOGICAL;

EID: 84857658550     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-011-0054-z     Document Type: Article

References (35)

1. The Liver Study Group of Japan. The 16th report: surveillance of primary liver cancer patients in National Registry. Kyoto: Liver Study Group of Japan (LCSGJ); 2005.
2. FA Casavila JW Marsh S Iwatsuki S Todo RG Lee R Madariaga, et al. 1997 Hepatic resection and transplantation for peripheral cholangiocarcinoma J Am Coll Surg 185 429 436 (Pubitemid 27475441)
3. WK Washburn WD Lewis RL Jenkins 1995 Aggressive surgical resection for cholangiocarcinoma Arch Surg 130 270 276 7534059 10.1001/archsurg.1995. 01430030040006 1:STN:280:DyaK2M7psVWqsw%3D%3D
4. S Roayaie JV Guarrena MQ Ye SN Thung S Emre TM Fishbein, et al. 1998 Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes J Am Coll Surg 187 365 372 9783782 10.1016/S1072-7515(98)00203-8 1:STN:280:DyaK1cvlsFWjsQ%3D%3D (Pubitemid 28467611)
5. S Isaji Y Kawarada H Taoka M Tabata H Suzuki H Yokoi 1999 Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan J Hepatobiliary Pancreat Surg 6 108 116 10398896 10.1007/s005340050092 1:STN:280:DyaK1MzivFemuw%3D%3D
6. K Shimamura I Kurosaki D Sato K Takano N Yokoyama Y Sato, et al. 2009 Intrahepatic cholangiocarcinoma arising 34 years after excision of a type IV-A congenital choledochal cyst: report of a case Surg Today 39 247 251 19280286 10.1007/s00595-008-3825-4
7. J Kacznski G Hanson S Wallerstedt 1988 Incidence, etiologic aspects and clinicopathological features in intrahepatic cholangiocarcinoma: a study of 51 cases from a low endemicity area Acta Oncol 37 77 83
8. KM Chu ECS Lai S Al-Hadeede CE Arcilla Jr CM Lo CL Liu, et al. 1997 Intrahepatic cholangiocarcinoma World J Surg 21 301 306 9015175 10.1007/s002689900233 1:STN:280:DyaK2s7mvV2juw%3D%3D (Pubitemid 27100493)
9. M Ohtsuka H Ito F Kimura H Shimizu A Togawa H Yoshidome, et al. 2003 Extended hepatic resection and outcomes in intrahepatic cholangiocarcinoma J Hepatobiliary Pancreat Surg 10 259 264 14598144 10.1007/s00534-002-0724-8 (Pubitemid 37407515)
10. M Yamamoto K Takasaki T Yoshikawa 1999 Extended resection for intrahepatic cholangiocarcinoma in Japan J Hepatobiliary Pancreat Surg 6 117 121 10398897 10.1007/s005340050093 1:STN:280:DyaK1MzivFelsg%3D%3D
11. RJ Langenbach PV Danenberg C Heidelberger 1972 Thymidylate synthase: mechanism of inhibition by 5-fluoro-2â€-deoxyuridylate Biochem Biophys Res Commun 48 1565 1571 4263280 10.1016/0006-291X(72)90892-3 1:CAS:528:DyaE38XlsV2jsLk%3D
12. GJ Peters CL van der Wilt B van Triest G Codacci-Pisanelli PG Johnston CJ van Groeningen, et al. 1995 Thymidylate synthase and drug resistance Eur J Cancer 31A 1299 1305 7577040 10.1016/0959-8049(95)00172-F 1:CAS:528: DyaK2MXotVOmt7s%3D
13. GD Heggie JP Sommadossi DS Cross WJ Huster RB Diasio 1987 Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine and bile Cancer Res 47 2203 2206 3829006 1:STN:280:DyaL2s7lvFaqtw%3D%3D (Pubitemid 17074634)
14. MC Etienne S Cheradame JL Fisschel P Formento O Dassonville N Rence, et al. 1995 Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity J Clin Oncol 13 1663 1670 7602356 1:STN:280:DyaK2MzisFyrtg%3D%3D
15. W Jiang Z Lu Y He RB Diasio 1997 Dihydropyrimidine dehydrogenase activity in hepatocellular carcinoma: implication in 5-fluorouracil-based chemotherapy Clin Cancer Res 3 395 399 9815697 1:CAS:528:DyaK2sXitVKms7g%3D (Pubitemid 27158063)
16. HL McLeod J Sludden GI Murray RA Keenan AI Davidson K Park, et al. 1998 Characterization of dihydropyrimidine dehydrogenase in human colorectal tumor Br J Cancer 77 461 465 9472644 10.1038/bjc.1998.73 1:STN:280:DyaK1c7jtF2rtA%3D%3D (Pubitemid 28044052)
17. W Ichikawa T Takahashi K Suto Z Nihei Y Shirota M Shimizu, et al. 2004 Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in relation to differentiation of gastric cancer Int J Cancer 112 967 973 15316940 10.1002/ijc.20511 1:CAS:528:DC%2BD2cXhtVSnsLjK (Pubitemid 39507002)
18. S Lassmann M Hennig R Rosenberg J Nahrig J Schreglmann F Krause, et al. 2006 Thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expression in primary colorectal tumors: correlation to tumor histopathology and clinical follow-up Int J Colorectal Dis 21 238 247 16132996 10.1007/s00384-005-0767-9 (Pubitemid 43280331)
19. Liver Cancer Study Group of Japan. Classification of primary liver cancer. 1st English edn. Tokyo: Kanehara; 1997.
20. RV Lord D Salonga KD Danenberg JH Peters TR DeMeester JM Park, et al. 2000 Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, carcinoma sequence Gastrointest Surg 4 135 142 10.1016/S1091-255X(00)80049-9 1:STN:280:DC%2BD3c7jvFKktA%3D%3D
21. CA Heid J Stevens KJ Livak PM Williams 1996 Real time quantitative PCR Genome Res 6 986 994 8908518 10.1101/gr.6.10.986 1:CAS:528:DyaK28XmsVWru7w%3D (Pubitemid 26388091)
22. UE Gibson CA Geid PM Williams 1996 A novel method for real time quantitative RT-PCR Genome Res 6 995 1011 8908519 10.1101/gr.6.10.995 1:CAS:528:DyaK28XmsVWru7s%3D
23. Y Fukui T Oka S Nagayama PV Danenberg KD Danenberg M Fukushima 2008 Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis Int J Mol Med 22 709 716 19020767 1:CAS:528:DC%2BD1MXks1Srtg%3D%3D
24. M Yamamoto K Takasaki T Yoshikawa K Ueno M Nakano 1998 Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma? J Surg Oncol 69 162 167 9846503 10.1002/(SICI)1096-9098(199811)69:3<162::AID-JSO8>3.0. CO;2-L 1:STN:280:DyaK1M%2FmtV2gtQ%3D%3D (Pubitemid 28549892)
25. FF Chou SM Sheen-Chen YS Chen MC Chen CL Chen 1997 Surgical treatment of cholangiocarcinoma Hepatogastroenterology 44 760 765 9222685 1:STN:280:DyaK2szmsFymug%3D%3D
26. M Shimada Y Yamashita S Aishima K Shirabe K Takenaka K Sugimachi 2001 Hepatectomy for intrahepatic cholangiocarcinoma Br J Cancer 88 1463 1466 1:STN:280:DC%2BD3MngvF2ntw%3D%3D
27. ZE El Rassi C Partensky JY Scoazec L Henry C Lombard-Bohas G Maddern 1999 Peripheral cholangiocarcinoma: presentation, diagnosis, pathology and management Eur J Surg Oncol 25 375 380 10419707 10.1053/ejso.1999.0660 1:STN:280:DyaK1MzltValuw%3D%3D (Pubitemid 29364223)
28. A Valveade N Bonhomme O Fagas A Sauvanet JF Flejou J Belghiti 1999 Resection of intrahepatic cholangiocarcinoma: a Western experience J Hepatobiliary Pancreat Surg 6 122 127 10.1007/s005340050094
29. M Otsuka H Ito F Kimura H Shimizu A Togawa H Yoshidome, et al. 2002 Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival Br J Cancer 89 1525 1531 (Pubitemid 35404319)
30. A Sasaki M Aramaki K Kawano Y Morii K Nakashima T Yoshida, et al. 1998 Intrahepatic peripheral cholangioma: mode of spread and choice of surgical treatment Br J Cancer 85 1206 1209 1:STN:280:DyaK1cvitlOrsA%3D%3D (Pubitemid 28430419)
31. M Tuchman RF O'Dea LR Ramnaraine BL Mirkin 1988 Pyrimidine base degradation in cultured murine C-1300 neuroblastoma cells and in situ tumors J Clin Invest 81 425 430 3339127 10.1172/JCI113336 1:CAS:528:DyaL1cXhvVCnt7g%3D (Pubitemid 18075235)
32. R Fujiwaki K Hata K Nakayama M Fukumoto K Miyazaki 2000 Gene expression for dihydropyrimidine dehydrogenase and thymidine phosphorylase influences outcome in epithelial ovarian cancer J Clin Oncol 18 3946 3951 11099324 1:CAS:528:DC%2BD3cXptVSiu7w%3D
33. H Baba K Teramoto T Kawamura A Mori M Imamura S Arii 2003 Dihydropyrimidine dehydrogenase and thymidylate synthase activities in hepatocellular carcinomas and in diseased livers Cancer Chemother Pharmacol 52 469 476 13680162 10.1007/s00280-003-0695-8 1:CAS:528:DC%2BD3sXovVKntb8%3D (Pubitemid 37491637)
34. A Nii M Shimada T Ikegami Y Harino S Imura Y Morine, et al. 2009 Significance of dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expressions in hepatocellular carcinoma Hepatol Res 39 274 281 19054147 10.1111/j.1872-034X.2008.00457.x 1:CAS:528:DC%2BD1MXktlKqsrs%3D
35. M Nishi M Shimada T Utsunomiya Y Morine S Imura T Ikemoto, et al. 2011 Role of dihydropyrimidine dehydrogenase and thymidylate synthase expression in immunohistochemistry of intrahepatic cholangiocarcinoma Hepatol Res 41 64 70 20880064 10.1111/j.1872-034X.2010.00722.x